News and Trends 6 Aug 2019
ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment
Two companies based in Lausanne, Switzerland — ADC Therapeutics and the genomics company SOPHiA Genetics — have signed a deal to identify patients most likely to respond to a blood cancer drug. ADC Therapeutics will send SOPHiA Genetics blood samples collected from an ongoing phase II trial. The trial is testing a treatment for patients […]